These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36863792)

  • 1. DNA methylation in the pathogenesis of type 2 diabetes.
    Kaimala S; Ansari SA; Emerald BS
    Vitam Horm; 2023; 122():147-169. PubMed ID: 36863792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: A systematic review.
    Muka T; Nano J; Voortman T; Braun KVE; Ligthart S; Stranges S; Bramer WM; Troup J; Chowdhury R; Dehghan A; Franco OH
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):553-566. PubMed ID: 27146363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes.
    Ling C
    J Intern Med; 2020 Aug; 288(2):158-167. PubMed ID: 32363639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.
    Hossan T; Kundu S; Alam SS; Nagarajan S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):775-786. PubMed ID: 30827271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetes.
    Gilbert ER; Liu D
    Epigenetics; 2012 Aug; 7(8):841-52. PubMed ID: 22810088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of type 2 diabetes related modules and genes based on epigenetic networks.
    Liu H; Wang T; Liu H; Wei Y; Zhao G; Su J; Wu Q; Qiao H; Zhang Y
    BMC Syst Biol; 2014; 8 Suppl 1(Suppl 1):S5. PubMed ID: 24565181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental origins of type 2 diabetes: Focus on epigenetics.
    Vaiserman A; Lushchak O
    Ageing Res Rev; 2019 Nov; 55():100957. PubMed ID: 31473332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus.
    Alam F; Islam MA; Gan SH; Mohamed M; Sasongko TH
    Curr Pharm Des; 2016; 22(28):4398-419. PubMed ID: 27229720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose Tissue Epigenetic Profile in Obesity-Related Dysglycemia - A Systematic Review.
    Andrade S; Morais T; Sandovici I; Seabra AL; Constância M; Monteiro MP
    Front Endocrinol (Lausanne); 2021; 12():681649. PubMed ID: 34290669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation as a diagnostic and therapeutic target in the battle against Type 2 diabetes.
    Rönn T; Ling C
    Epigenomics; 2015; 7(3):451-60. PubMed ID: 26077431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Modifications Linked to T2D, the Heritability Gap, and Potential Therapeutic Targets.
    Szabó M; Máté B; Csép K; Benedek T
    Biochem Genet; 2018 Dec; 56(6):553-574. PubMed ID: 29872933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes.
    Nilsson E; Jansson PA; Perfilyev A; Volkov P; Pedersen M; Svensson MK; Poulsen P; Ribel-Madsen R; Pedersen NL; Almgren P; Fadista J; Rönn T; Klarlund Pedersen B; Scheele C; Vaag A; Ling C
    Diabetes; 2014 Sep; 63(9):2962-76. PubMed ID: 24812430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation in the pathogenesis of type 2 diabetes in humans.
    Davegårdh C; García-Calzón S; Bacos K; Ling C
    Mol Metab; 2018 Aug; 14():12-25. PubMed ID: 29496428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-Genome Bisulfite Sequencing of Human Pancreatic Islets Reveals Novel Differentially Methylated Regions in Type 2 Diabetes Pathogenesis.
    Volkov P; Bacos K; Ofori JK; Esguerra JL; Eliasson L; Rönn T; Ling C
    Diabetes; 2017 Apr; 66(4):1074-1085. PubMed ID: 28052964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide methylation analysis identifies ELOVL5 as an epigenetic biomarker for the risk of type 2 diabetes mellitus.
    Hwang JY; Lee HJ; Go MJ; Jang HB; Choi NH; Bae JB; Castillo-Fernandez JE; Bell JT; Spector TD; Lee HJ; Kim BJ
    Sci Rep; 2018 Oct; 8(1):14862. PubMed ID: 30291282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin-mediated epigenetic modifications in diabetes and associated conditions: Biological and clinical relevance.
    Giordo R; Posadino AM; Mangoni AA; Pintus G
    Biochem Pharmacol; 2023 Sep; 215():115732. PubMed ID: 37541452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on epigenetics as a missing link between obesity and type 2 diabetes.
    Dobosz AM; Dziewulska A; Dobrzyń A
    Postepy Biochem; 2018 Oct; 64(2):157-165. PubMed ID: 30656898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered DNA methylation in liver and adipose tissues derived from individuals with obesity and type 2 diabetes.
    Barajas-Olmos F; Centeno-Cruz F; Zerrweck C; Imaz-Rosshandler I; Martínez-Hernández A; Cordova EJ; Rangel-Escareño C; Gálvez F; Castillo A; Maydón H; Campos F; Maldonado-Pintado DG; Orozco L
    BMC Med Genet; 2018 Feb; 19(1):28. PubMed ID: 29466957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment?
    Raciti GA; Desiderio A; Longo M; Leone A; Zatterale F; Prevenzano I; Miele C; Napoli R; Beguinot F
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease.
    Stols-Gonçalves D; Tristão LS; Henneman P; Nieuwdorp M
    Curr Diab Rep; 2019 May; 19(6):31. PubMed ID: 31044315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.